COLLATERAL THERAPEUTICS has a total of 17 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Canada, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals and biotechnology are GEMVAX AS, GENE SIGNAL INT SA and MULTHOFF GABRIELE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | New Zealand | 3 | |
#4 | Australia | 2 | |
#5 | China | 2 | |
#6 | United States | 2 | |
#7 | Israel | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Bohlen Peter | 7 |
#2 | Andreason Grai | 3 |
#3 | Baird Andrew | 3 |
#4 | Engler Robert L | 2 |
#5 | Peter Bohlen | 1 |
#6 | Insel Paul A | 1 |
#7 | Gao Mei Hua | 1 |
#8 | Ping Peipei | 1 |
#9 | Keshet Eli | 1 |
#10 | Post Steven R | 1 |
Publication | Filing date | Title |
---|---|---|
AU2451002A | Gene therapy for congestive heart failure | |
AU7250298A | Truncated vegf-related proteins |